Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rhodiola rosea adjunctive therapy with first-line anti-tuberculosis treatment in elderly pulmonary tuberculosis
ChiCTR2300071928Phase 4Not yet recruiting
- Sponsor
- Shanghai Public Health Clinical Center
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Vitano in pulmonary tuberculosis (TB), sponsored by Shanghai Public Health Clinical Center. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
Vitano
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on ChiCTR2300071928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071928.